Title (en)

NOVEL ORALLY ADMINISTERED DOSAGE FORM FOR 3-[(2-{[4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO]-METHYL}-1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO]-ETHYL PROPRIONATE AND SALTS THEREOF

Title (de)

NEUE ORAL ZU APPLIZIERENDE DARREICHUNGSFORM FÜR 3-[(2-{[4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO}-METHYL}-1-METHYL-1H-BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO -PROPIONSÄURE-ETHYLESTER UND DESSEN SALZE

Title (fr)

NOUVELLE FORME GALENIQUE ORALE POUR ETHYLESTER D'ACIDE 3- (2- 4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYLE)-PHENYLAMINO -METHYLE-1-METHYLE-1H-BENZIMIDAZOL-5-CARBONYLE)-PYRIDINE-2-YLE-AMINO PROPIONIQUE ET SES SELS

Publication

EP 1663209 A1 20060607 (DE)

Application

EP 04764593 A 20040828

Priority

• EP 2004009619 W 20040828
• DE 10341043 A 20030903

Abstract (en)

[origin: WO2005023249A1] The invention relates to a novel orally administered dosage form for the active substance 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-ethyl proprionate and pharmacologically compatible salts thereof.

IPC 1-7

A61K 31/4184; A61K 9/66; A61K 47/14; A61K 9/107

IPC 8 full level

A61K 9/48 (2006.01); A61K 9/66 (2006.01); A61K 31/4184 (2006.01); A61K 9/107 (2006.01); A61K 47/14 (2006.01)

CPC (source: EP)

A61K 9/4858 (2013.01); A61K 31/4184 (2013.01); A61P 7/02 (2017.12); A61K 9/1075 (2013.01); A61K 9/4866 (2013.01); A61K 47/14 (2013.01)

Citation (search report)

See references of WO 2005023249A1

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2005023249 A1 20050317; CA 2537480 A1 20050317; DE 10341043 A1 20050331; EP 1663209 A1 20060607; JP 2007504190 A 20070301

DOCDB simple family (application)

EP 2004009619 W 20040828; CA 2537480 A 20040828; DE 10341043 A 20030903; EP 04764593 A 20040828; JP 2006525085 A 20040828